highlight af symposium
pfa ai rise innov
disclosur statu non-u analyst us disclosur credit suiss seek busi compani cover research
report result investor awar firm may conflict interest could affect object report investor consid
report singl factor make invest decis
background introduct
attend year annual af symposium meet last week dc
primari focu atrial fibril afib ablat confer usual
precursor sort upcom heart rhythm societi hr meet may
came away increment updat outperform-r
also met number emerg privat compani well
highlight slide
hot topic year af symposium includ puls field ablat
pfa use artifici intellig ai map diagnosi
pfa use puls electr field high voltag short time
period select target heart muscl tissu ablat creat lesion
potenti faster safe convent system research
pfa progress sever year fda recent
approv mdt us trial rise clinician interest base
check clinician meet expect hear much
pfa next month tune
artifici intellig benefit map diagnosi help
gener effect use map patient arrhythmia
substanti shorter period time remain earli s-
curv applic adopt ai treatment afib
number compani lead charg least one
commerci inheart highlight later report remain impress
speed develop commerci adopt ai
machin learn comput vision technolog across
expect key theme drive univers
receiv fda approv begin ide studi pfa treatment af
announc receiv fda approv start trial evalu
safeti effect pulseselect puls field ablat pfa
pfa use non-therm energi select target cardiomyocyt heart muscl cell
reduc impact nerv esophagu compar current
commerci form ablat use radiofrequ heat cryotherapi cold
ablat tissu indiscrimin manner injur nearbi phrenic nerv
esophagu
pfa irrevers electropor ire pois next-gen platform
technolog cathet ablat af everi major player research underway
puls af prospect multi-cent non-random unblend ww studi
enrol patient treat mdt pulseselect pfa expect
addit updat hr meet earli may mdt investor day june
attend lunch symposium dr chee gate vascular institut
provid thought experi mdt arctic front cryoballoon
cryoballoon procedur date
overal dr found cryoballoon ablat treatment af effect
practic
dr found cryoballoon demonstr higher rate durabl lesion vs
radiofrequ lead long-term freedom af practic
need repeat ablat cryo vs rf month
cryoballoon procedur time hour averag practic
dr also highlight arctic front cryoballoon single-cent studi
demonstr cryoballoon ablat effect durabl pvi translat
year freedom af greater across number center
charl martineau pm univers toronto highlight
emphas strength market-lead map
continu highlight power carto map system creat real-tim
map cardiac structur arrhythmia
new carto prime modul featur map solut call map help
simplifi diagnosi scar-rel complex atrial arrhythmia also help identifi slower
conduct compar rest chamber
cartofind modul expand carto map system includ irregular atrial
arrhythmia parallel map featur allow simultan map differ
arrhythmia use cathet locat
highlight confirmrx implant monitor perclos proglid
abt confirmrx implant cardiac monitor help physician remot diagnos treat
difficult detect cardiac arrhythmia
confirmrx incorpor sharpsens technolog analyz previou second
presenc well absenc p-wave characterist
sharpsens also help bradycardia detect base confirmrx algorithm
improv accuraci measur af bradycardia episod
abt perclos proglid vascular closur system use larg bore femor access
case tavr help reduc infect length stay
continu enhanc expand rhythmia map platform
bsx rhythmia hdx map system combin high-definit cardiac map
compani intellamap orion map cathet intellanav famili ablat cathet
rhythmia system rhythmia expect featur hardwar platform
combin cardiac map algorithm process data creat hd map
hakon bergheim provid updat adagio
adagio ultra-low temperatur cryoablat cathet util interchang stylet
allow unlimit shape ablat diagnost section cathet
icla cryoablat system oper temperatur degress celsiu vs
degre celsiu current commerci system
one shot cryoablat cathet make continu transmur lesion combin
ablat diagnost cathet cathet also elimin need
electromagnet map util anatom approach guid navig
adagio eu trial persist af on-going expect complet
mr bergheim indic ep current complet persist af case
minut icla vs hour averag persist af case
adagio recent enrol first patient trial aim evalu safeti
efficaci adagio icla system treatment persist atrial fibril trial
enrol expect complet put potenti launch
inheart medic imag ai
met jean-marc peyrat ceo co-found inheart whose compani
gener map heart ct mri medic imag use ai base imag
process use pre-op structur diagnosi identifi ablat target
inheart use ai enhanc standard imag qualiti autom segment base
databas scan use algorithm identifi abnorm tissu
reduc need diagnost cathet also result much shorter
diagnosi time hour compar hour typic spent diagnosi cath lab
inheart current network center ww patient treat
ce mark achiev management expect approv year
kardium globe map ablat system
ceo kevin chaplin provid us comprehens overview globe map
ablat system provid rapid pulmonari vein isol high resolut map
atrial ablat singl devic
globe cathet contain array electrod deploy insid left atrium
insid atrium measur electrod simultan
combin high-resolut anatom electr map
kardium expect ce mark approv next month sale expect later
compani also expect health canada approv later year
fda studi start year enrol expect complet fda
approv expect
stephen sagon presid ceo gave us overview retractor
esophag balloon retractor intend move esophagu away potenti injuri
af ablat
deploy esophagu inflat balloon provid deviat
esophagu place away anatomi procedur complet devic
deflat remov patient
present dr mark marieb note rare rate complic
atrio-esophag fistula late complic af ablat procedur result massiv
thermal injuri esophagu surround structur underreport
dr marieb use case note devic move esophagu
enough prevent signific temperatur rise therebi allow increas effect
effici ablat due uninterrupt energi deliveri desir target without
affect esophagu
charl martineau pm univers toronto select privat non-cov compani highlight
cover biomed signal process platform
ken london founder chairman ceo provid comprehens overview pure
ep aim minim nois acquir high-fidel cardiac signal assist
ep identifi area tissu creat arrhythmia
improv signal clariti potenti help improv accuraci effici ablat
procedur well minim need repeat procedur
late last year compani sign three licens agreement mayo clinic
start patient case mayo clinic florida texa
compani also start first clinic trial pure ep studi aim submit trial
data abstract consider upcom hr meet may
pure ep receiv fda clearanc august
founder ceo mr matthiesen highlight cathvis low-nois ep
record system help better guid ablat therapi improv ep signal qualiti
consol reject nois improv signal qualiti mean patent amplifi design
interfac exist cathet compat exist map system
system also featur softwar user interfac provid real-tim analysi well
product consist consol proprietari softwar stream analyz store ep
compani expect enter clinic trial later year sale expect
regulatori approach facilit earli stage devic innov
fda provid comprehens overview four fda earli stage program
recent propos step program
draft safer technolog program medic devic step propos program
support devic target diseases/condit less seriou elig
breakthrough devic program offer signific safeti advantag either
treatment diagnosi
similar benefit breakthrough devic program includ
higher placement fda review queue
breakthrough devic program voluntari program certain medic devic
device-l combin product contain drug biolog compon
provid effect treatment diagnosi life-threaten irrevers
debilit diseas condit
program appli submiss type pma de novo
benefit includ fda interact emphasi flexibl studi design
post-market data well alloc addit resourc senior
earli feasibl studi program allow earli clinic evalu devic
provid proof principl initi clinic safeti data appli signific risk
key benefit program allow studi devic clinic
inform need advanc develop
q-sub pre-submiss program mechan request fda feedback
clinic studi design regulatori pathway well anim test
charl martineau pm univers toronto compani mention price abt biosig bsgm corp bsx johnson johnson jnj medtron plc mdt disclosur appendix analyst certif matt miksic vik chopra certifi respect compani secur individu analyz view express report accur reflect person view subject compani secur part compens directli indirectli relat specif recommend view express report price rate histori abt abt close price target price date us us rate signifi initi assumpt coverag outperform price rate histori corp bsx bsx close price target price date us us rate signifi initi assumpt coverag outperform price rate histori johnson johnson jnj jnj close price target price date us us rate signifi initi assumpt coverag restrictedneutraloutperform price rate histori medtron plc mdt mdt close price target price date us us rate signifi initi assumpt coverag outperform decemb analyst stock rate defin follow outperform stock total return expect outperform relev benchmark next month neutral stock total return expect line relev benchmark next month under-perform stock total return expect under-perform relev benchmark next month relev benchmark region decemb japanes rate base stock total return rel analyst coverag univers consist compani cover analyst within relev sector outperform repres attract neutral less attract underperform least attract invest opportun octob canadian well european exclud turkey rate base stock total return rel analyst coverag univers consist compani cover analyst within relev sector outperform repres attract neutral less attract underperform least attract invest opportun latin america turkey asia exclud japan australia stock rate base stock total return rel averag total return relev countri region benchmark india bse sensex index prior octob canadian rate base stock absolut total return potenti current share price rel attract stock total return potenti within analyst coverag univers australian new zealand stock expect total return calcul includ roll dividend yield outperform rate assign greater equal under-perform less equal neutral may assign overlap rate rang allow analyst assign rate put context associ risk prior may rang outperform under-perform rate overlap neutral threshold oper juli restrict certain circumst credit suiss polici and/or applic law regul preclud certain type commun includ invest recommend cours credit suiss engag invest bank transact certain circumst rate nr credit suiss equiti research invest rate view stock secur relat compani time cover nc credit suiss equiti research provid on-going coverag compani offer invest rate invest view equiti secur compani relat product volatil indic stock defin volatil stock price move month least past month analyst expect signific volatil go forward analyst sector weight distinct analyst stock rate base analyst expect fundament and/or valuat sector rel group histor fundament and/or valuat overweight analyst expect sector fundament and/or valuat favor next month market weight analyst expect sector fundament and/or valuat neutral next month underweight analyst expect sector fundament and/or valuat cautiou next month analyst coverag sector consist compani cover analyst within relev sector analyst may cover multipl sector credit suiss distribut stock rate bank client global rate distribut rate versu univers bank client outperform/buy bank client neutral/hold bank client underperform/sel bank client restrict purpos nyse finra rate distribut disclosur requir stock rate outperform neutral under-perform close correspond buy hold sell respect howev mean stock rate determin rel basi pleas refer definit investor decis buy sell secur base invest object current hold individu factor import global disclosur credit suiss research report made avail client proprietari research portal cs credit suiss research product may also made avail third-parti vendor altern electron mean conveni certain research product made avail cs servic provid credit suiss analyst client may depend specif client prefer regard frequenc manner receiv commun client risk profil invest size scope overal client relationship firm well legal regulatori constraint access credit suiss research entitl receiv time manner pleas contact sale repres go http //plu credit-suiss com credit suiss polici updat research report deem appropri base develop subject compani sector market may materi impact research view opinion state herein charl martineau pm univers toronto credit suiss polici publish invest research imparti independ clear fair mislead detail pleas refer credit suiss polici manag conflict interest connect invest research http //www credit-suiss com/sites/disclaimers-ib/en/managing-conflict html inform relat tax statu financi instrument discuss herein intend provid tax advic use anyon provid tax advic investor urg seek tax advic base particular circumst independ tax profession credit suiss decid enter busi relationship compani credit suiss determin involv develop manufactur acquisit anti-personnel mine cluster munit credit suiss posit issu pleas see analyst respons prepar research report receiv compens base upon variou factor includ credit suiss total revenu portion gener credit suiss invest bank activ compani mention section full compani name credit suiss expect receiv intend seek invest bank relat compens subject compani bsx mdt within next month credit suiss member credit suiss group market maker liquid provid secur follow subject issuer abt bsx jnj mdt date time product dissemin histori recommend subject compani featur report dissemin within past month pleas refer link import region disclosur singapor recipi contact credit suiss ag singapor branch matter aris research report analyst involv prepar report may particip event host subject compani includ site visit credit suiss accept permit analyst accept payment reimburs travel expens associ event credit suiss secur canada inc polici procedur regard dissemin equiti research pleas visit http //www credit-suiss com/sites/disclaimers-ib/en/canada-research-polici html investor note incom secur financi instrument may fluctuat price valu secur instrument may rise fall case investor may lose entir princip invest research report author credit suiss secur usa llc matt miksic vik chopra import disclosur regard compani subject report avail call import disclosur except valuat methodolog risk discuss also avail credit suiss disclosur websit http //rave credit-suiss com/disclosur valuat methodolog risk associ recommend price target rate referenc report pleas refer disclosur section recent report regard subject compani report produc subsidiari affili credit suiss oper global market divis inform structur pleas use follow link http //www credit-suiss com/who-we-ar report may contain materi direct intend distribut use person entiti citizen resid locat local state countri jurisdict distribut public avail use would contrari law regul would subject credit suiss affili cs registr licens requir within jurisdict materi present report unless specif indic otherwis copyright cs none materi content copi may alter way transmit copi distribut parti without prior express written permiss cs trademark servic mark logo use report trademark servic mark regist trademark servic mark cs affili inform tool materi present report provid inform purpos use consid offer solicit offer sell buy subscrib secur financi instrument cs may taken step ensur secur refer report suitabl particular investor cs treat recipi report custom virtu receiv report invest servic contain refer report may suitabl recommend consult independ invest advisor doubt invest invest servic noth report constitut invest legal account tax advic represent invest strategi suitabl appropri individu circumst otherwis constitut person recommend pleas note particular base level taxat may chang inform opinion present report obtain deriv sourc believ cs reliabl cs make represent accuraci complet cs accept liabil loss aris use materi present report except exclus liabil appli extent liabil aris specif statut regul applic cs report reli upon substitut exercis independ judgment cs may issu may futur issu commun inconsist reach differ conclus inform present report commun reflect differ assumpt view analyt method analyst prepar cs oblig ensur commun brought attent recipi report invest refer report offer sole singl entiti case invest sole cs associ cs cs may market maker invest past perform taken indic guarante futur perform represent warranti express impli made regard futur perform inform opinion estim contain report reflect judgment origin date public cs subject chang without notic price valu incom secur financi instrument mention report fall well rise valu secur financi instrument subject exchang rate fluctuat may posit advers effect price incom secur financi instrument investor secur adr valu influenc currenc volatil effect assum risk structur secur complex instrument typic involv high degre risk intend sale sophist investor capabl understand assum risk involv market valu structur secur may affect chang econom financi polit factor includ limit spot forward interest exchang rate time matur market condit volatil credit qualiti issuer refer issuer investor interest purchas structur product conduct investig analysi product consult profession advis risk involv make purchas invest discuss report may high level volatil high volatil invest may experi sudden larg fall valu caus loss invest realis loss may equal origin invest inde case invest potenti loss may exceed amount initi invest circumst may requir pay money support loss incom yield invest may fluctuat consequ initi capit paid make invest may use part incom yield invest may readili realis may difficult sell realis invest similarli may prove difficult obtain reliabl inform valu risk invest expos report may provid address contain hyperlink websit except extent report refer websit materi cs cs review site take respons content contain therein address hyperlink includ address hyperlink cs websit materi provid sole conveni inform content websit way form part document access websit follow link report cs websit shall risk report issu distribut european union except switzerland credit suiss secur europ limit one squar london england authoris prudenti regul author regul financi conduct author prudenti regul author germani credit suiss deutschland aktiengesellschaft regul bundesanstalt fuer finanzdienstleistungsaufsicht bafin ed state canada credit suiss secur usa llc switzerland credit suiss ag brazil banco de investimento credit suiss brasil affili mexico banco credit suiss mxico institucin de banca mltipl grupo financiero credit suiss mxico de bolsa credit suiss mxico de grupo financiero credit suiss mxico credit suiss mexico document prepar inform purpos exclus distribut mexico institut investor credit suiss mexico respons onward distribut report non-institut investor third parti author report receiv payment compens entiti compani relev credit suiss group compani employ japan credit suiss secur japan limit financi instrument firm director-gener kanto local financ bureau kinsho member japan secur dealer associ financi futur associ japan japan invest advis associ type ii financi instrument firm associ hong kong credit suiss hong kong limit australia credit suiss equiti australia limit thailand credit suiss secur thailand limit regul offic secur exchang commiss thailand regist address abdulrahim place floor rama iv silom bangrak thailand tel malaysia credit suiss secur malaysia sdn bhd singapor credit suiss ag singapor branch india credit suiss secur india privat limit cin regul secur exchang board india research analyst registr inh stock broker registr regist address floor ceejay hous dr worli mumbai india t- south korea credit suiss secur europ limit seoul branch taiwan credit suiss ag taipei secur branch indonesia pt credit suiss sekurita indonesia philippin credit suiss secur philippin inc elsewher world relev authoris affili addit region disclaim australia credit suiss secur europ limit cssel credit suiss intern csi authoris prudenti regul author regul financi conduct author fca prudenti regul author uk law differ australian cssel csi hold australian financi servic licenc afsl exempt requir hold afsl corpor act cth corpor act respect financi servic provid australian wholesal client within mean section corpor act hereinaft refer financi servic materi distribut retail client direct exclus credit suiss profession client elig counterparti defin fca wholesal client defin section corpor act credit suiss hong kong limit cshk licens regul secur futur commiss hong kong law hong kong differ australian law cshkl hold afsl exempt requir hold afsl corpor act respect provid financi servic invest bank servic ed state provid credit suiss secur usa llc affili credit suiss group cssu regul ed state secur exchang commiss ed state law differ australian law cssu hold afsl exempt requir hold afsl corpor act respect provid financi servic credit suiss asset manag llc csam authoris secur exchang commiss us law differ australian law csam hold afsl exempt requir hold afsl corpor act respect provid financi servic materi provid sole institut account defin finra rule elig contract particip defin us commod exchang act credit suiss equiti australia limit abn cseal afsl holder australia afsl malaysia research provid resid malaysia authoris head research credit suiss secur malaysia sdn bhd direct queri singapor report prepar issu distribut singapor institut investor accredit investor expert investor defin financi advis regul also distribut credit suiss ag singapor branch oversea investor defin financi advis regul credit suiss ag singapor branch may distribut report produc foreign entiti affili pursuant arrang regul financi advis regul singapor recipi contact credit suiss ag singapor branch matter aris connect report virtu statu institut investor accredit investor expert investor oversea investor credit suiss ag singapor branch exempt compli certain complianc requir financi advis act chapter singapor faa financi advis regul relev notic guidelin issu thereund respect financi advisori servic credit suiss ag singapor branch may provid eu report produc subsidiari affili credit suiss oper global market divis jurisdict cs alreadi regist licens trade secur transact effect accord applic secur legisl vari jurisdict jurisdict may requir trade made accord applic exempt registr licens requir materi issu distribut cssu member nyse finra sipc nfa cssu accept respons content client contact analyst execut transact credit suiss subsidiari affili home jurisdict unless govern law permit otherwis pleas note research origin prepar issu cs distribut market profession institut investor custom recipi market profession institut investor custom cs seek advic independ financi advisor prior take invest decis base report necessari explan content cs may provid variou servic us municip entiti oblig person municip includ suggest individu transact trade enter transact servic cs provid municip view advic within mean section dodd-frank wall street reform consum protect act cs provid servic relat inform sole arm length basi advisor fiduciari municip connect provis servic agreement direct indirect municip includ offici manag employe agent thereof cs cs provid advic municip municip consult financi account legal advisor regard servic provid cs addit cs act direct indirect compens solicit municip behalf unaffili broker dealer municip secur dealer municip advisor invest advis purpos obtain retain engag municip connect municip financi product issuanc municip secur invest advis provid invest advisori servic behalf municip report distribut financi institut credit suiss ag affili financi institut sole respons distribut client institut contact institut effect transact secur mention report requir inform report constitut invest advic credit suiss client distribut financi institut neither credit suiss ag affili respect offic director employe accept liabil whatsoev direct consequenti loss aris use report content inform commun provid herein otherwis intend constru recommend within mean us depart labor final regul defin invest advic purpos employe retir incom secur act amend section intern revenu code amend inform provid herein intend gener inform constru provid invest advic imparti otherwis copyright credit suiss ag and/or affili right reserv purchas non-list japanes fix incom secur japanes govern bond japanes municip bond japanes govern guarante bond japanes corpor bond cs seller request pay purchas price charl martineau pm univers toronto
